Digestive Health11 min read·Published October 9, 2026

Treatment for Crohn's Disease: Medicines, Diet, Flares, and When to Get Care

A patient guide to Crohn’s symptoms, diagnosis, medications, nutrition therapy, surgery, flare red flags, and where Chia does—and does not—fit.

Treatment for Crohn's Disease: Medicines, Diet, Flares, and When to Get Care

Crohn’s disease treatment aims to reduce symptoms, heal intestinal inflammation, prevent flares, and manage complications. Options may include corticosteroids for short-term flares, immunomodulators, biologics, targeted small-molecule medicines, nutrition therapy, antibiotics for certain complications, and sometimes surgery. The right plan depends on disease location, severity, prior treatment response, and risks 1.

Not sure where to start? Take the 3-min clinical quiz.

See if you qualify →

What is Crohn’s disease, and why does treatment matter?

Crohn’s disease is a chronic inflammatory bowel disease, or IBD, that causes immune-driven inflammation in the digestive tract. Treatment matters because symptoms may improve before inflammation is fully controlled, and ongoing inflammation can raise the risk of strictures, fistulas, abscesses, malnutrition, anemia, and surgery 1.

How Crohn’s differs from ulcerative colitis

Crohn’s disease can involve the mouth, small intestine, colon, rectum, or area around the anus. Ulcerative colitis usually affects the colon and rectum in a more continuous pattern. Both are forms of IBD, but their location, depth of inflammation, complications, and treatment decisions can differ 1. For a broader overview, see our guide to inflammatory bowel disease treatment.

Why symptom control is not the same as inflammation control

A person may feel better while the bowel lining is still inflamed, or feel symptoms from scarring, infection, irritable bowel syndrome, bile acid diarrhea, or food intolerance rather than active Crohn’s. This is why clinicians often use C-reactive protein, fecal calprotectin, imaging, colonoscopy, ileoscopy, and biopsy to check objective inflammation 1.

Common treatment goals: remission, mucosal healing, fewer flares, and fewer complications

Modern Crohn’s care often aims beyond short-term symptom relief. Clinical trials and expert reviews commonly measure clinical remission, endoscopic response, endoscopic remission, and safety over time 2. In a post hoc analysis of SONIC trial data, endoscopic activity scores were validated as ways to measure Crohn’s inflammation seen during endoscopy 4.

What are the main symptoms of Crohn’s disease?

Crohn’s symptoms often include diarrhea, abdominal pain, fatigue, weight loss, and sometimes blood in the stool. Symptoms can also happen outside the gut, including joint, skin, eye, liver, and growth problems in children 1.

  • Diarrhea that keeps coming back or wakes you from sleep
  • Cramping or pain, often in the lower right belly but not always
  • Fatigue, low appetite, or unplanned weight loss
  • Blood in the stool or rectal bleeding
  • Fever, nausea, vomiting, or signs of dehydration during a flare
  • Pain, swelling, or drainage near the anus, which can suggest a fistula or abscess
  • Joint pain, eye redness, skin sores, mouth ulcers, or liver-test changes

Symptoms like diarrhea and abdominal pain can have many causes, including infection, medication effects, food intolerance, celiac disease, and irritable bowel syndrome. Persistent or severe digestive symptoms should be evaluated rather than self-diagnosed; our guide to intestinal inflammation symptoms explains common warning patterns.

How is Crohn’s disease diagnosed before treatment starts?

Crohn’s diagnosis usually combines symptoms, exam findings, blood tests, stool tests, endoscopy, biopsy, and imaging. No single symptom proves Crohn’s disease, so objective testing matters before long-term treatment starts 1.

A clinician may check blood counts for anemia or infection, C-reactive protein for inflammation, stool tests for infection, and fecal calprotectin for bowel inflammation. Colonoscopy with ileoscopy lets the clinician inspect the colon and end of the small intestine, while biopsy can show microscopic inflammation 1.

CT enterography, MRI enterography, ultrasound in some centers, or capsule imaging may be used when small-bowel disease is suspected. These tests help find strictures, fistulas, abscesses, and bowel obstruction, which can change the treatment plan 1.

What is the best thing to do for Crohn’s disease?

The best first step for suspected Crohn’s disease is to see a gastroenterology clinician for diagnosis, risk assessment, and a treatment plan. Crohn’s care is personalized; the right choice depends on inflammation severity, disease location, complications, prior medicines, and safety risks 3.

  1. 1Confirm the diagnosis with objective testing rather than symptoms alone.
  2. 2Assess risk: disease location, ulcers, strictures, fistulas, abscesses, weight loss, anemia, smoking, prior surgery, and medication history.
  3. 3Treat active inflammation early when appropriate, because uncontrolled inflammation can lead to damage over time 1.
  4. 4Track symptoms, weight, labs, stool markers, imaging or endoscopy results, and medication response.
  5. 5Avoid smoking. Smoking is linked with worse Crohn’s outcomes in clinical reviews 1.
  6. 6Discuss NSAID use, such as ibuprofen or naproxen, with a clinician because these medicines may worsen symptoms or complicate care in some people with IBD 1.
Your situationSensible next stepWhy it matters
New diarrhea, belly pain, weight loss, or blood in stoolSee a primary care clinician or gastroenterologist for labs, stool tests, and possible endoscopyCrohn’s can look like infection or other gut conditions, so testing guides care
Known Crohn’s with mild symptom changeContact your gastroenterology team and track stool frequency, pain, weight, fever, and medication changesA flare, infection, medication issue, or non-inflammatory trigger may need different care
Severe pain, fever, vomiting, dehydration, heavy bleeding, or fast weight lossSeek urgent care or emergency careThese can signal obstruction, abscess, severe flare, infection, or dangerous dehydration
Symptoms improve but labs or stool markers stay highAsk about objective inflammation monitoringFeeling better is important, but ongoing inflammation can still cause damage
Poor appetite, low weight, anemia, or fatigueAsk about nutrition labs, iron, B12, vitamin D, and dietitian supportCrohn’s can cause malnutrition and anemia that need targeted care

Which medicines are used to treat Crohn’s disease?

Crohn’s medicines may include short-term corticosteroids, immunomodulators, biologics, targeted oral medicines, and antibiotics for specific complications. Benefits must be weighed against side effects, infection risk, pregnancy plans, cancer history, liver and blood-test monitoring, and prior treatment response 1.

Corticosteroids and budesonide for short-term flare control

Prednisone and other systemic corticosteroids can calm inflammation during flares, and budesonide may be used for certain disease locations. They are generally not a long-term maintenance strategy because repeated or prolonged use can cause bone loss, high blood sugar, mood changes, infection risk, cataracts, and adrenal suppression 1.

Immunomodulators such as azathioprine, 6-mercaptopurine, and methotrexate

Immunomodulators reduce immune activity and may be used in selected Crohn’s patients, sometimes to support maintenance or reduce antibody formation with biologics. Methotrexate has been studied for relapse prevention in Crohn’s disease, but it requires careful monitoring and is not safe in pregnancy 5.

Azathioprine and 6-mercaptopurine can affect blood counts and the liver, and they may raise infection and certain cancer risks in some patients. Clinicians often check blood tests and medication-interaction risks before and during treatment 1.

Anti-TNF biologics such as adalimumab and infliximab

Anti-TNF medicines block tumor necrosis factor, an inflammatory signal involved in Crohn’s disease. In the CLASSIC-I randomized trial, adalimumab was studied in adults with moderate to severe Crohn’s disease and showed efficacy compared with placebo; individual results vary, and infection screening and monitoring are required 6.

Other biologics and targeted therapies, including IL-12/23, IL-23, anti-integrin, and JAK-pathway options

Other biologic classes target different immune pathways. Vedolizumab is an anti-integrin therapy that works mainly by affecting immune-cell trafficking to the gut. Ustekinumab targets the IL-12/23 pathway, and risankizumab targets IL-23; extended risankizumab treatment has been studied in Crohn’s patients who did not respond after induction treatment 7.

Oral small-molecule medicines, including JAK-pathway options such as upadacitinib, may be considered for certain patients. These medicines can carry risks such as serious infections, lab changes, shingles, blood clots, or cardiovascular warnings depending on the drug and patient risk profile, so they require clinician screening and follow-up 1.

Antibiotics for abscesses, fistulas, or infections when indicated

Antibiotics are not a universal Crohn’s treatment. They may be used when a clinician suspects infection, abscess, perianal disease, or certain fistula-related complications. Some abscesses also need drainage or surgery, not antibiotics alone 1.

Why 5-ASA medicines have a limited role in Crohn’s disease

Aminosalicylates, also called 5-ASA medicines, are more central in ulcerative colitis than Crohn’s disease. Reviews of Crohn’s management describe a limited role for 5-ASA in Crohn’s compared with biologics, immunomodulators, corticosteroids for induction, and other targeted approaches 1.

How do biologics and targeted therapies compare?

Biologics and targeted therapies differ by immune target, route, speed, monitoring needs, and safety profile. The choice is not one-size-fits-all; a gastroenterology clinician weighs disease pattern, prior response, infection risks, pregnancy plans, other illnesses, and patient preference 3.

Drug classExamplesHow they workRouteTypical use caseKey safety checks
Anti-TNF therapyAdalimumab, infliximabBlocks tumor necrosis factor, a major inflammatory signalInjection or infusionModerate to severe Crohn’s, fistulizing disease in some casesTB, hepatitis B, infections, infusion or injection reactions, labs
Anti-integrin therapyVedolizumabLimits certain immune-cell movement into gut tissueInfusion or injection depending on product and settingModerate to severe Crohn’s when a gut-selective approach is consideredInfections, liver tests, prior therapy history, follow-up response
IL-12/23 or IL-23 pathway therapyUstekinumab, risankizumabTargets inflammatory cytokine pathways involved in immune signalingInfusion induction and/or injection depending on productModerate to severe Crohn’s, including after other treatment failuresTB and infection screening, labs, response monitoring
JAK-pathway small moleculeUpadacitinibAffects intracellular inflammatory signalingOral tabletSelected moderate to severe cases after clinician risk reviewInfections, shingles, blood counts, liver tests, lipids, clot and heart-risk review
ImmunomodulatorAzathioprine, 6-mercaptopurine, methotrexateBroadly reduces immune activityOral or injection depending on drugSelected maintenance strategies or combination plansBlood counts, liver tests, pregnancy review, infection and cancer-risk discussion

Before starting many biologics or targeted immune medicines, clinicians often screen for tuberculosis, hepatitis B, active infections, vaccination gaps, and baseline lab problems. During treatment, follow-up looks at symptoms, side effects, labs, stool markers, and sometimes endoscopy or imaging 1.

Can diet or nutrition therapy treat Crohn’s disease?

Crohn’s nutrition care can reduce symptoms, correct deficiencies, and in some cases help control inflammation, especially with exclusive enteral nutrition. Diet should not be treated as a universal replacement for medication, because Crohn’s severity and complications vary widely 8.

Exclusive enteral nutrition and formula-based therapy

Exclusive enteral nutrition means getting all or nearly all calories from a prescribed liquid formula for a set period under medical supervision. Elemental and polymeric diets have been studied in Crohn’s disease, including a comparison reported by Matsui and colleagues in 1995 8. This approach may be used more often in children or selected adults, but it takes support and monitoring.

Diet changes for symptom triggers versus inflammation treatment

Some foods can worsen diarrhea, gas, pain, or urgency during active inflammation or strictures. That does not always mean the food is causing inflammation. A clinician or dietitian can help separate symptom triggers from malnutrition risk, especially when many foods have been removed.

Protein, calories, iron, B12, vitamin D, and malnutrition concerns

Crohn’s can reduce appetite, raise calorie needs, and impair absorption of nutrients such as iron, vitamin B12, vitamin D, and protein. Fatigue can come from inflammation, anemia, poor intake, sleep disruption, or medication effects; our guide to fatigue and loss of appetite covers common causes to discuss with a clinician.

When to ask about a dietitian

Ask about a dietitian if you are losing weight, avoiding many foods, dealing with strictures, having frequent diarrhea, recovering from surgery, or planning exclusive enteral nutrition. Nutrition support is part of Crohn’s care, not a sign that symptoms are “all in your head.”

When is surgery needed for Crohn’s disease?

Crohn’s surgery may be needed for strictures, bowel obstruction, fistulas, abscesses, perforation, severe bleeding, or disease that is not controlled with medicine. Surgery can remove or repair damaged bowel, but it is not a cure because Crohn’s can come back in other areas 1.

Common surgical situations include a narrowed bowel segment that blocks food or stool, an abscess that needs drainage, a fistula that causes infection or drainage, or severe inflammation that does not respond to medicine. After surgery, many patients still need gastroenterology follow-up and sometimes medication to reduce recurrence risk 1.

How long can a Crohn’s flare-up last?

A Crohn’s flare can last days, weeks, or longer depending on severity, trigger, complications, and treatment response. Because infection, obstruction, abscess, medication changes, and non-Crohn’s causes can mimic a flare, prolonged or severe symptoms should be checked by a clinician 1.

Some mild symptom changes can be handled outpatient with your gastroenterology team, especially if you can drink fluids, have no fever, and pain is manageable. Urgent evaluation is safer when symptoms include severe or worsening pain, fever, repeated vomiting, dehydration, heavy rectal bleeding, black stools, fainting, or rapid weight loss.

What is the life expectancy for people with Crohn’s disease?

Many people with Crohn’s disease live active lives with treatment and monitoring. Risk can be affected by severe inflammation, infections, surgery, nutrition problems, smoking, medication side effects, and cancer surveillance needs 1.

Regular care matters even during remission because inflammation can return quietly, and long-term risks may need monitoring. A gastroenterology team can decide when colon cancer surveillance, lab checks, vaccine review, bone-health review, or medication adjustments are needed 1.

Does Chia treat Crohn’s disease?

Chia does not currently offer Crohn’s disease diagnosis or treatment. We do not provide gastroenterology care, biologic therapy, corticosteroids, immunomodulators, antibiotics for Crohn’s complications, bowel imaging, colonoscopy, biopsy, surgery, or emergency care.

If you have suspected or known Crohn’s disease, the right clinician is usually a gastroenterologist, with urgent care or emergency care for severe symptoms. Chia’s current offerings should not be presented or used as Crohn’s disease treatments.

We do write about related health topics because patients often search for answers before they know what is going on. For educational next steps, you may find our guides to inflammatory bowel disease treatment, intestinal inflammation symptoms, and low-dose naltrexone side effects helpful. These articles do not replace gastroenterology care.

When should you get help now?

Get medical help now for severe Crohn’s symptoms or symptoms that could signal dehydration, bleeding, obstruction, infection, or abscess. Waiting can be risky when pain, fever, vomiting, or bleeding is significant 1.

  • Severe or worsening abdominal pain
  • Fever, chills, or feeling very ill
  • Persistent vomiting or inability to keep fluids down
  • Signs of dehydration, such as dizziness, very dark urine, or fainting
  • Heavy rectal bleeding, black stools, or blood clots
  • Rapid unplanned weight loss
  • Swollen, painful, or draining area near the anus
  • Symptoms of bowel obstruction, such as belly swelling, vomiting, and inability to pass stool or gas

References

  1. 1.Lichtenstein GR, Loftus EV Jr, Isaacs KL, et al. Management of Crohn Disease: A Review. JAMA. 2022.
  2. 2.U.S. Food and Drug Administration. Crohn’s Disease: Developing Drugs for Treatment. Guidance Document. 2022.
  3. 3.Seyedian SS, Nokhostin F, Malamir MD. Personalized Treatment for Crohn’s Disease. Journal of Clinical Medicine. 2023.
  4. 4.Ferrante M, Colombel JF, Sandborn WJ, et al. Validation of Endoscopic Activity Scores in Patients With Crohn's Disease Based on a Post Hoc Analysis of Data From SONIC. Gastroenterology. 2013.
  5. 5.Roseau E. Crohn's Disease: Prevention of Relapse With Methotrexate or Growth Hormone. Presse Médicale. 2000.
  6. 6.Hanauer SB, Sandborn WJ, Rutgeerts P, et al. Human Anti-Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn's Disease: The CLASSIC-I Trial. Gastroenterology. 2006.
  7. 7.Panaccione R, Ferrante M, Dotan I, et al. Extended Risankizumab Treatment in Patients With Crohn's Disease Who Did Not Achieve Clinical Response to Induction Treatment. Clinical Gastroenterology and Hepatology. 2025.
  8. 8.Matsui T, Ueki M, Yamada M, et al. Indications and Options of Nutritional Treatment for Crohn's Disease: A Comparison of Elemental and Polymeric Diets. Journal of Gastroenterology. 1995.
  9. 9.Schölmerich J. Diet Therapy of Crohn's Disease. Deutsche Medizinische Wochenschrift. 1994.
  10. 10.Gisbert JP, Chaparro M. Comparison of the FDA and EMA Guidance on Drug Development for Crohn’s Disease. Therapeutic Advances in Gastroenterology. 2025.

About this article

Chia Health Editorial Team — Evidence-reviewed health education

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.

Get a personalized plan

Find what fits your body and your goals.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides